📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Expression of a novel mycobacterial phosphodiesterase successfully lowers cAMP levels resulting in reduced tolerance to cell wall-targeting antimicrobials. (2022)

First Author: Thomson M

Attributed to: MRC Centre for Molecular Bacteriology and Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbc.2022.102151

PubMed Identifier: 35718063

Publication URI: http://europepmc.org/abstract/MED/35718063

Type: Journal Article/Review

Volume: 298

Parent Publication: The Journal of biological chemistry

Issue: 8

ISSN: 0021-9258